Hrt Financial LP Verrica Pharmaceuticals Inc. Transaction History

Hrt Financial LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$2.88 - $8.51 $76,216 - $225,208	26,464 New	26,464 $172,000
Q3 2022 Nov 14, 2022	BUY	$2.17 - $4.3 $2,745 - $5,439	1,265 Added 12.47%	11,411 $33,000
Q2 2022 Aug 12, 2022	BUY	$1.81 - $8.93 $18,364 - $90,603	10,146 New	10,146 $19,000

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.